Trial Profile
A Phase II Study of Flavopiridol [alvocidib] 1 Hour Bolus Days 1-3 Q 21 Days in Patients With Advanced Renal Cell Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Alvocidib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 20 Sep 2005 New trial record.